According to a new study published in the Journal of Clinical Oncology, a blood test along with a risk model based on person’s history can more accurately find whether the person can benefit from lung cancer screening or not. The study included participants from the Prostate, Lung, Colorectal and Ovarian Cancer screening trial with at